Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bright Minds Biosciences Inc (DRUG)

Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bright Minds Biosciences Inc 19 VESTRY STREET NEW YORK NY 10013 USA

www.brightmindsbio.com P: 64-7407-2515

Description:

Bright Minds Biosciences is a biotechnology company. It focused on developing novel drugs for targeted treatment of neuropsychiatric disorders, epilepsy and pain. Bright Minds Biosciences is based in VANCOUVER, British Columbia.

Key Statistics

Overview:

Market Capitalization, $K 4,389
Enterprise Value, $K -611
Shares Outstanding, K 4,434
Annual Sales, $ 0 K
Annual Net Income, $ -5,470 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,240 K
EBIT, $ -5,040 K
EBITDA, $ -4,990 K
60-Month Beta 1.45
% of Insider Shareholders 42.66%
% of Institutional Shareholders 40.52%
Float, K 2,542
% Float 57.34%
Short Volume Ratio 0.16

Growth:

1-Year Return -67.67%
3-Year Return -95.74%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.32 on 02/12/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -1.31
EPS Growth vs. Prev Qtr -6.67%
EPS Growth vs. Prev Year 36.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 07/14/23

DRUG Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -91.83%
Return-on-Assets % -83.54%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.05
Book Value/Share 1.00
Interest Coverage -2.09
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar